Descrição

Cardiac biomarkers are of great importance in the timely, accurate diagnosis and management of acute coronary syndrome as well as the prognosis. Diagnosis in the golden period is of utmost importance to institute therapy at the earliest and possibly reverse the myocardial damage. Cardiac biomarkers are also a powerful tool for triaging. De acordo com um relatório da StrategyHelix, the global cardiac biomarkers market is set to increase by US$ 7.1 bilhão durante 2022-2028, crescendo em um CAGR de 9.3% durante o período de previsão.

O relatório fornece dados atualizados sobre o tamanho do mercado para o período 2018-2021 e previsão para 2028 covering key market aspects like sales value for cardiac biomarkers. The global cardiac biomarkers market is segmented on the basis of type, location of testing, aplicativo, and region. On the basis of type, the global cardiac biomarkers market has been segmented into albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, outros. By location of testing, the global cardiac biomarkers market has been segmented into laboratory testing, point of care testing. Based on application, the global cardiac biomarkers market is categorized into acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, outros. Geographically, the global cardiac biomarkers market is segmented into North America, Ásia-Pacífico, Europa, Rest of the World (ROW).

The global cardiac biomarkers market is highly competitive. The cardiac biomarkers market is dominated by key players, which are Abbott Laboratories, ACS Biomarker B.V., bioMerieux S.A., Bio-Rad Laboratories Inc., Danaher Corporation, F. Hoffmann-La Roche AG, Johnson & Johnson, Novartis AG, QuidelOrtho Corporation, Randox Laboratories Ltd., Siemens AG, Thermo Fisher Scientific Inc., Tosoh Bioscience Inc.

O relatório é um recurso inestimável para empresas e organizações ativas neste setor. It provides a cohesive picture of the cardiac biomarkers market to help drive informed decision making for industry executives, decisores políticos, acadêmico, e analistas.

Escopo do relatório

Tipo: albumin, creatine kinase-MB (CK-MB), low-density lipoproteins (LDL) and high-density lipoproteins (HDL), myoglobin, natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP), troponins, outros
Location of testing: laboratory testing, point of care testing
Aplicativo: acute coronary syndrome, atherosclerosis, congestive heart failure, myocardial infarction, outros
Região: América do Norte, Ásia-Pacífico, Europa, Rest of the World (ROW)
Anos considerados: este relatório cobre o período 2018 para 2028

Principais benefícios para as partes interessadas

– Get a comprehensive picture of the global cardiac biomarkers market
– Identifique setores de crescimento e tendências para investimento

Índice

Papel 1. Introdução
– Escopo do estudo
– Período de estudos
– Escopo geográfico
– Metodologia de Pesquisa
Papel 2. Cardiac biomarkers market overview
Papel 3. Market breakdown by type
– Albumin
– Creatine kinase-MB (CK-MB)
– Low-density lipoproteins (LDL) and high-density lipoproteins (HDL)
– Myoglobin
– Natriuretic peptides – B-type natriuretic peptide (BNP) & N-terminal pro b-type natriuretic peptide (NT-proBNP)
– Troponins
– Outros
Papel 4. Market breakdown by location of testing
– Laboratory testing
– Point of care testing
Papel 5. Market breakdown by application
– Acute coronary syndrome
– Atherosclerosis
– Congestive heart failure
– Myocardial infarction
– Outros
Papel 6. Market breakdown by region
– América do Norte
– Ásia-Pacífico
– Europa
– Rest of the World (ROW)
Papel 7. Principais empresas
– Abbott Laboratories
– ACS Biomarker B.V.
– bioMerieux S.A.
– Bio-Rad Laboratories, Inc..
– Danaher Corporation
– F. Hoffmann-La Roche AG
– Johnson & Johnson
– Novartis AG
– QuidelOrtho Corporation
– Randox Laboratories Ltd.
– Siemens AG
– Thermo Fisher Scientific Inc.
– Tosoh Bioscience, Inc..
Sobre StrategyHelix
Isenção de responsabilidade